Login
Users of this system, can login to view this document.
Enter the following information to request a copy of the document from the responsible person.
A levodopa-encapsulated poly-ε-caprolactone nanocomposite lmproves the motor symptoms and neurochemical changes in a rotenone-induced mouse model of parkinson’s disease